The US Patent and Trademark Office (USPTO) has granted an US patent to the InSite Vision’s DuraSite 2 next-generation enhanced drug delivery system, which will be valid up to 2029 for internal pipeline and partnering. Offering a ...
Tags: Drug Delivery System
InSite Vision has launched a new DuraSite 2 drug delivery system, designed to deliver ophthalmic therapeutics. DuraSite 2, which is based on InSite DuraSite technology, incorporates cataract surgery drug, ketorolac, a non-steroidal ...
Tags: InSite, Ophthalmic Drug Delivery System, ophthalmic therapeutics